Biosynthesis and engineering of isoprenoid small molecules

Withers, Sydnor T.; Keasling, Jay D.
December 2006
Applied Microbiology & Biotechnology;Dec2006, Vol. 73 Issue 5, p980
Academic Journal
Isoprenoid secondary metabolites are a rich source of commercial products that have not been fully explored. At present, there are isoprenoid products used in cancer therapy, the treatment of infectious diseases, and crop protection. All isoprenoids share universal prenyl diphosphate precursors synthesized via two distinct pathways. From these universal precursors, the biosynthetic pathways to specific isoprenoids diverge resulting in a staggering array of products. Taking advantage of this diversity has been the focus of much effort in metabolic engineering heterologous hosts. In addition, the engineering of the mevalonate pathway has increased levels of the universal precursors available for heterologous production. Finally, we will describe the efforts to produce to commercial terpenoids, paclitaxel and artemisinin.


Related Articles

  • Perspectives and limits of engineering the isoprenoid metabolism in heterologous hosts. Muntendam, Remco; Melillo, Elena; Ryden, Annamargareta; Kayser, Oliver // Applied Microbiology & Biotechnology;Oct2009, Vol. 84 Issue 6, p1003 

    Terpenoids belong to the largest class of natural compounds and are produced in all living organisms. The isoprenoid skeleton is based on assembling of C5 building blocks, but the biosynthesis of a great variety of terpenoids ranging from monoterpenoids to polyterpenoids is not fully understood...

  • Biosynthesis of isoprenoids via the non-mevalonate pathway. Eisenreich, W.; Bacher, A.; Arigoni, D.; Rohdich, F. // Cellular & Molecular Life Sciences;Jun2004, Vol. 61 Issue 12, p1401 

    The mevalonate pathway for the biosynthesis of the universal terpenoid precursors, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), is known in considerable detail. Only recently, the existence of a second mevalonate-independent pathway for the biosynthesis of IPP and DMAPP...

  • Good yews.  // New Scientist;2/19/94, Vol. 141 Issue 1913, p12 

    Reports on the synthesis of taxol, an anticancer drug. Alternative source to Pacific yew; Yew's scarcity; Approval by Food and Drug Administration for treatment of ovarian cancer.

  • Isoprenoid biosynthesis in chloroplasts via the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE) fromArabidopsis thalianais a [4Fe-4S] protein. Seemann, Myriam; Wegner, Patrick; Sch�nemann, Volker; Bui, Bernadette; Wolff, Murielle; Marquet, Andr�e; Trautwein, Alfred; Rohmer, Michel // Journal of Biological Inorganic Chemistry;Mar2005, Vol. 10 Issue 2, p131 

    The mevalonate-independent methylerythritol phosphate pathway is widespread in bacteria. It is also present in the chloroplasts of all phototrophic organisms. Whereas the first steps, are rather well known, GcpE and LytB, the enzymes catalyzing the last two steps have been much less...

  • Mutations in Escherichia coli aceE and ribB Genes Allow Survival of Strains Defective in the First Step of the Isoprenoid Biosynthesis Pathway. Perez-Gil, Jordi; Uros, Eva Maria; Sauret-Güeto, Susanna; Lois, L. Maria; Kirby, James; Nishimoto, Minobu; Baidoo, Edward E. K.; Keasling, Jay D.; Boronat, Albert; Rodriguez-Concepcion, Manuel; McCutcheon, John // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    A functional 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway is required for isoprenoid biosynthesis and hence survival in Escherichia coli and most other bacteria. In the first two steps of the pathway, MEP is produced from the central metabolic intermediates pyruvate and glyceraldehyde...

  • Structure-based Drug Design Targeting Biosynthesis of Isoprenoids: A Crystallographic State of the Art of the Involved Enzymes. de Ruyck, J.; Wouters, J. // Current Protein & Peptide Science;Apr2008, Vol. 9 Issue 2, p117 

    Biosynthesis of the universal terpenoid precursors, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), from three acetyl CoA moieties through mevalonate was studied extensively in the 1950s. For several decades, the mevalonate paradigm reigned supreme and a mevalonate origin...

  • Taxanes: perspectives for biotechnological production. Frense, Dieter // Applied Microbiology & Biotechnology;Jan2007, Vol. 73 Issue 6, p1233 

    Taxol is a valuable plant-derived drug showing activity against various cancer types. Worldwide efforts had been made to overcome the supply problem, because the supply by isolation from the bark of the slow-growing yew trees is limited. Plant cell cultures as well as chemical and...

  • Computational identification of gene over-expression targets for metabolic engineering of taxadiene production. Boghigian, Brett; Armando, John; Salas, Daniel; Pfeifer, Blaine // Applied Microbiology & Biotechnology;Mar2012, Vol. 93 Issue 5, p2063 

    Taxadiene is the first dedicated intermediate in the biosynthetic pathway of the anticancer compound Taxol. Recent studies have taken advantage of heterologous hosts to produce taxadiene and other isoprenoid compounds, and such ventures now offer research opportunities that take advantage of the...

  • Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis. Köksal, Mustafa; Jin, Yinghua; Coates, Robert M.; Croteau, Rodney; Christianson, David W. // Nature;1/6/2011, Vol. 469 Issue 7328, p116 

    With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics